Patient-Focused Medical Product Development Webinar Series: A Look at Rare Disease Listening Sessions with NORD and the FDA

  • Event Date: Jan. 31, 2020
  • Event Time: 1:00 p.m.
  • Event Location: 

Our first webinar of 2020 will feature Debbie Drell, Director of Membership, at the National Organization for Rare Diseases (NORD), and Andrea Furia-Helms, Director, Patient Affairs Staff at Food and Drug Administration (FDA) to discuss their collaboration on Rare Disease Patient Listening Sessions. The listening sessions are facilitated by FDA Patient Affairs Staff and offer patients and caregivers an opportunity to speak directly to FDA staff about what it’s like to live with a specific rare disease. The sessions help FDA staff understand the patients’ perspective about their disease, needed treatment options, and meaningful outcomes. 

Other Webinars

Optimizing Digital Health Trials by Engaging Patients and Sites

01/12/2021 2:00 pm, Virtual, Zoom

Register now for this webinar on Jan. 12 at 2 p.m. Speakers include, Virginia Nido, Global Head, Product Development Industry Collaborations, Genentech; and Cindy Geoghegan, Patient Advocate.

Read More

Health Literacy Throughout Drug Development: Why it Matters to Pharma and to Patients

09/24/2020 3:00 pm, Zoom

Read More

Patient-Focused Medical Product Development: Real-World Case Examples

08/13/2020 2:00 pm, Zoom

Read More

What is the Role of Patient-Reported Data in Outcomes-Based Contracts?

03/23/2020 2:00 pm, Webex

Read More

Observer-reported or Proxy-reported: Is One Better than the Other?

02/24/2020, Webex

Read More

A Look at Rare Disease Listening Sessions with NORD and the FDA


Read More
« Previous 1 2 3